JEANNETTE SULLIVAN: Open Payments
NPI 1952419566 · MARSHALL, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 20 payments from 9 companies in 2025. Trend: 2023 $379 · 2024 $86 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $322 |
| Medtronic, Inc. | 1 | $27 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Ascensia Diabetes Care Us Inc. | 1 | $19 |
| Abbott Laboratories | 1 | $18 |
| Amgen Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: Ozempic, MINIMED 780G, TZIELD, JARDIANCE, LEQVIO, FREESTYLE LIBRE 3, TEPEZZA, MOUNJARO.
Industry payments across MI — which companies pay providers there.
